Science Explorer Interactive view Map

Andrographolide Research and Applications

Andrographolide Research and Applications is a research topic within Complementary and alternative medicine. Science Explorer counts 3.8k research works in it since 1960. 28.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the medicinal properties of Andrographis paniculata, particularly its bioactive compound andrographolide, and its potential applications in anticancer, immunostimulatory, anti-inflammatory, antioxidant, hepatoprotective, and antiviral treatments.

  • Andrographis Paniculata
  • Andrographolide
  • Anticancer
  • Immunostimulatory
  • Anti-inflammatory
  • Antioxidant
  • Hepatoprotective
  • Antiviral
  • Pharmacological Activities
  • Bioactive Compounds
Research works
3.8k
fractional, since 1960
In the world top 10%
1.1k
per year above
Top-10% rate
28.0%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+72%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Andrographolide Research and Applications research?

By volume, China and India publish the most (436 and 255 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 436 works
  2. 2 India 255 works
  3. 3 Indonesia 88 works
  4. 4 Thailand 44 works
  5. 5 United States 41 works
  6. 6 Nigeria 30 works
  7. 7 Iran 27 works
  8. 8 Malaysia 23 works
  9. 9 South Korea 21 works
  10. 10 Egypt 20 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 44.2%India: 25.9%Indonesia: 8.9%Thailand: 4.5%6 others listed: 16.5%44%largest
China436 · 44.2%India255 · 25.9%Indonesia88 · 8.9%Thailand44 · 4.5%6 others listed162 · 16.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Andrographolide Research and Applications research?

By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Andrographolide Research and Applications research, followed by Beijing University of Chinese Medicine and Chengdu University of Traditional Chinese Medicine.

Where is Andrographolide Research and Applications research done?

The largest centres of Andrographolide Research and Applications research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Bangkok (Thailand). Among places with at least 20 works in it, it is an unusually large share of all research in Bangkok and Chennai.

Largest cities, 2022–2025

  1. 1 Beijing China 65 works
  2. 2 Guangzhou China 35 works
  3. 3 Shanghai China 28 works
  4. 4 Bangkok Thailand 23 works
  5. 5 Chennai India 23 works
  6. 6 Chengdu China 20 works
  7. 7 Hangzhou China 19 works
  8. 8 New Delhi India 17 works
  9. 9 Tianjin China 14 works
  10. 10 Jinan China 13 works

Where it is the local speciality

  1. BangkokTH · 23.1 works8.8×
  2. ChennaiIN · 22.6 works4.2×
← less than its size predictsmore →

Location quotient: how much more of its research is in Andrographolide Research and Applications than the world average.

See Andrographolide Research and Applications on the map

Where is the best place to study Andrographolide Research and Applications?

Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing University of Chinese Medicine and Chengdu University of Traditional Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 31.4%fractional works in this node (log) →share in the world top 10% →Chinese Academy of Medical Sciences & Peking Union Medical College: 16, 27.2%Beijing University of Chinese Medicine: 12, 26.7%Chengdu University of Traditional Chinese Medicine: 11, 37.4%Guangzhou University of Chinese Medicine: 10, 34.7%Shanghai University of Traditional Chinese Medicine: 9, 31.0%Chengdu University o…Guangzhou University…Chinese Academy of M…Beijing University o…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 49.427.2%14.8×16 -41.5%
2 Beijing University of Chinese MedicineChina 45.326.7%61.3×12 +76.1%
3 Chengdu University of Traditional Chinese MedicineChina 40.237.4%44.4×11 -13.0%
4 Guangzhou University of Chinese MedicineChina 36.934.7%49.2×10 -30.2%
5 Shanghai University of Traditional Chinese MedicineChina 29.531.0%43.4×9 -17.2%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Andrographolide Research and Applications research growing?

Output in 2018–2022 was 72% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Andrographolide Research and Applications.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.